Duration of Chest Tube Suction in Traumatic Pneumothorax

March 12, 2022 updated by: Michael J Nabozny, MD, University of Rochester

Chest Tube Management in Traumatic Pneumothorax: Does Duration of Suction Matter

The purpose of this pilot study is to determine whether chest tube suction duration, 24 hours vs 48 hours, prior to water seal affects outcome and length of stay after placement for traumatic pneumothorax.

Study Overview

Status

Withdrawn

Intervention / Treatment

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • Rochester, New York, United States, 14642
        • University of Rochester Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Trauma service consult/patient
  • Traumatic pneumothorax with chest tube placed within 0-24 hours of presentation and confirmation of adequate position
  • Age >18
  • Blunt or penetrating mechanism
  • Chest tubes sizes 14 to 32Fr
  • Chest tubes placed by residents on the trauma surgery service supervised by attending trauma surgeons or placed by the attending surgeon themselves
  • Presence of single chest tube in one or both pleural cavities (single unilateral or bilateral tubes)
  • Subjects with decision making capacity (DMC) who are able to provide written consent. DMC will be determined by the consenting physician through a teach back mechanism. Subjects must demonstrate understanding of the situation, appreciation of the consequences of their decision, reasoning of their thought process, and be able to communicate their wishes.

Exclusion Criteria:

  • Age <18
  • Pregnant patients
  • Prisoners
  • Mechanically ventilated in ICU for more than 24 hours while chest tube in place
  • Chest tubes placed as part of, or present during, a thoracic operation
  • History of surgery involving pleural cavity ipsilateral to chest tube
  • Subjects with more than one chest tube on the ipsilateral side at any time prior to study chest tube removal
  • Subjects with chylothorax or empyema
  • Subjects with chest tubes that are withdrawn or removed unintentionally
  • Subjects with known or suspected bronchial injury
  • Subjects with bullous emphysema.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 24 hours of suction
Subjects with chest tubes kept to -20 cmH2O suction for 24 hours prior to water seal
The chest tubes will be inserted using our institutional standard chest tube insertion tray. The chest tubes used will be our institutional standard and will range from 14 to 32Fr in size. After chest tube placement, an Atrium Oasis Dry Suction Water Seal Chest Drain (Getinge USA Sales, LLC) will be used.
Experimental: 48 hours of suction
Subjects with chest tubes kept to -20 cmH2O suction for 48 hours prior to water seal
The chest tubes will be inserted using our institutional standard chest tube insertion tray. The chest tubes used will be our institutional standard and will range from 14 to 32Fr in size. After chest tube placement, an Atrium Oasis Dry Suction Water Seal Chest Drain (Getinge USA Sales, LLC) will be used.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chest tube dwell time
Time Frame: up to 1 month
Total time that chest tube is in place from insertion to removal
up to 1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with reaccumulation of pneumothorax
Time Frame: up to 3 days
After transition to water seal and stopping suction, incidence of reaccumulation of pneumothorax requiring suction or replacement of chest tube.
up to 3 days
Number of participants with at least one pulmonary complications
Time Frame: up to 1 week
Pulmonary complications are defined as increased oxygen requirements, shortness of breath or unplanned intubations following placement to suction.
up to 1 week
Readmission to hospital
Time Frame: 30 days
Number of participants readmitted to the hospital within 30 days
30 days
Transfer to ICU
Time Frame: up to 1 week
Number of participants with an unplanned transfer to the intensive care unit
up to 1 week
Median length of stay
Time Frame: Up to 1 year
Median length of stay in the hospital after chest tube placement
Up to 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

October 1, 2021

Primary Completion (Anticipated)

April 1, 2023

Study Completion (Anticipated)

May 1, 2023

Study Registration Dates

First Submitted

July 22, 2021

First Submitted That Met QC Criteria

July 22, 2021

First Posted (Actual)

August 3, 2021

Study Record Updates

Last Update Posted (Actual)

March 29, 2022

Last Update Submitted That Met QC Criteria

March 12, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00005364

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Traumatic Pneumothorax

Clinical Trials on Chest tube suction

Subscribe